查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
心臟生物植入设备市场：规模、全球市场预测（2023-2030）、行业趋势、增长、份额、前景、通货膨胀的影响、公司机会分析
市场调查报告书
商品编码
1338995

心臟生物植入设备市场：规模、全球市场预测（2023-2030）、行业趋势、增长、份额、前景、通货膨胀的影响、公司机会分析

Cardiac Bio Implant Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
出版日期: | 出版商: Renub Research | 英文 210 Pages | 商品交期: 最快1-2个工作天内

价格

到 2030 年，全球心臟生物植入设备市场规模预计将达到 602 亿美元。 全球最常见的死亡原因是心血管疾病（CVD），其特点是血管收缩，增加心脏病发作和中风的风险。 冠状动脉旁路移植术（CABG）和经皮冠状动脉介入治疗（PCI）等外科手术通常用于恢復血流。

然而，患者仍然面临因移植失败和支架内再狭窄 (ISR) 等结果导致疾病恶化和死亡率增加的风险。 为了解决这些问题，研究人员正在开发具有传感器和实时跟踪功能的先进心血管生物植入物。 为了防止 ISR 和移植失败，这些技术力求及早发现疾病症状，甚至在症状出现之前。

预计 2022 年至 2030 年，全球心臟生物植入物市场规模将以 7.13% 的复合年增长率扩大。

市场扩张的主要驱动力是生物植入治疗的吸引力不断增强，与关节镜检查和物理治疗等替代治疗相比，生物植入治疗的价格和生物相容性更好，因此受到人们的欢迎。 由于骨科和心血管疾病患病率的提高、老年人口的增加、生存的转变、整容手术的增加等，预计该市场将会增长。

根据美国疾病控制与预防中心的数据，冠心病是美国最常见的冠心病，影响超过 2010 万名 20 岁及以上的人。 据估计，美国每年有805,000人心脏病发作，每40秒就有一个人心脏病发作。 慢性病的增加可能会进一步增加对生物植入物的需求。 预计到 2022 年，全球心臟生物植入市场价值将达到 347 亿美元。

本报告考察了全球心臟生物植入设备市场，并提供了市场概述，包括按类型、应用、最终用户、国家/地区以及参与市场的公司概况划分的趋势。我是。

目录

第一章简介

第二章研究方法

第 3 章执行摘要

第 4 章市场动态

第五章心臟生物植入装置市场

第 6 章市场份额 - 心臟生物植入设备市场

  • 按类型
  • 按用途
  • 按最终用户
  • 按国家/地区

第七章类型-心臟生物植入设备市场

  • 起搏器
  • ICD（植入式心臟復律除颤器）
  • CRT（心臟再同步治疗）

第 8 章应用 - 心臟生物植入设备市场

  • 心律失常
  • 心肌缺血
  • 急性心肌梗死
  • 心力衰竭

第 9 章最终用户 - 心臟生物植入设备市场

  • 医院
  • 门诊手术中心
  • 心导管实验室
  • 其他

第10章国家-心臟生物植入装置市场

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲
  • 其他领域

第 11 章波特五力分析 - 心臟生物植入设备市场

第十二章 SWOT 分析 - 心臟生物植入设备市场

第十三章主要公司分析

  • F.霍夫曼-拉罗氏
  • F. Hoffman-La Roche
  • Eurofins Scientific
  • Illumina, Inc
  • Natera Inc
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Quest Diagnostics
  • Agilent Technologies

Global Cardiac Bio-Implants Device Market size is estimated to be US$ 60.20 Billion by 2030, according to Renub Research. The most common cause of mortality worldwide is cardiovascular disease (CVD), which is characterized by constricted blood vessels that raise the risk of heart attacks and strokes. Blood flow restoration frequently involves surgical procedures, including coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI).

However, sufferers are nonetheless at danger for consequences which includes graft failure and in-stent restenosis (ISR) that may worsen their condition and boom mortality. Researchers are developing sophisticated cardiovascular bioimplants with sensors and actual-time tracking talents to address these issues. In order to prevent ISR and graft failure, those technologies are trying to find to discover ailment symptoms early, even before signs seem.

Worldwide cardiac bio-implants Market is predicted to show off a CAGR of 7.13% at some point of the period 2022-2030

A large driving force of market expansion is the growing attractiveness of bio-implant treatments that are desired over alternatives like arthroscopy and physical therapy due to their better fulfillment prices and biocompatibility. The market will grow as a result of things consisting of the improved prevalence of orthopedic and cardiovascular illnesses, the old aged populace, converting existence, and the growing use of beauty surgical operation.

According to data from the Centers for Disease Control and Prevention, coronary heart disorder, this influences over 20.1 million people elderly 20 and over, is the most commonplace form of coronary heart disease in the USA. An anticipated 805,000 heart attacks arise annually in the US, with one happening each 40 seconds. The growing incidence of chronic situations further will increase the demand for bioimplants. The global cardiac bio-implants market changed into worth USD 34.70 Billion in 2022.

Rising target sickness occurrence, heart assault incidence, remedy investment, and healthcare spending are driving the cardiac resynchronization remedy marketplace growth

The Cardiac Bio-Implant Device market is categorized into pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT). There are several motives why the CRT market is expanding. These consist of the high incidence of coronary coronary heart sickness, the upward push in heart failure and other cardiac problems, in addition to the growing range of aged people for the duration of the arena. The worldwide attractiveness of CRT is being driven by way of unhealthy existence and cardiovascular danger factors include diabetes, obesity, bad diets, state of no activity, and excessive alcohol use. These elements also make contributions to the improved incidence of heart disease. By 2050, a considerable part of the populace in the Asia-Pacific area is anticipated to be elderly, increasing the occurrence of cardiovascular sickness and the need for CRT.

Increasing product releases are anticipated to drive market expansion throughout the projected period. For instance, in February 2021, Medtronic unveiled the TYRX absorbable Antibacterial envelope. This unique, single-use envelope has antibacterial qualities and is made to support cardiac implantable electronic devices or implanted neurostimulators.

Rising number of people with cardiovascular disorders is predicted to propel the market for cardiac arrhythmias to considerable growth over the coming years, opening up attractive business prospects

By Application, The Cardiac Bio-Implant Device market is segmented into Arrhythmias, Myocardial Ischemia, Acute Myocardial infarction, and Heart Failure. A number of variables, such as the rising global incidence of unhealthy lifestyle choices like smoking, binge drinking, and obesity, which increase a person's susceptibility to cardiac arrhythmias, are fueling the expansion of the arrhythmias sector. Additionally, increasing patient awareness helps the market grow. When the heart beats too slowly, too fast, or irregularly, arrhythmias happen.

According to projections, 12.1 million Americans will have AFib by 2030. In 2019, 183,321 death certificates listed AFib as a contributing factor in 26,535 fatalities. Since AFib is associated with aging and women have greater life expectancies than men, it affects more women than men in Europe compared to African Americans. An important factor propelling the sector is the elevated death rate linked to arrhythmias. The industry is predicted to expand significantly over the next several years because of the rising number of individuals with cardiovascular disorders.

With the growing inclination for less invasive treatments in the Cardiac Catheterization laboratory sector, fluoroscopy-guided catheter-based cardiology operations have increased dramatically over the past several decades

By End User, The cardiac bio-implant device market is divided into Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization laboratories, and others. The growth of the Cardiac Catheterization laboratory market is primarily fueled by the increasing prevalence of cardiovascular disorders and advancements in Cardiac Catheterization lab technology. The rising incidence of cardiac diseases is expected to drive demand for Cardiac Catheterization lab services, which utilize various imaging techniques like angiography, echocardiography, and cardiac catheterization for diagnosis. For example, according to statistics from the British Heart Foundation, approximately 1,139,140 individuals were projected to be affected by heart and circulatory diseases in the UK in 2022, with 650,681 males and 488,320 females among them.

Globally, the American Heart Association estimates that during 2020, 244.1 Million humans may be living with ischemic coronary heart disorder (IHD), with a higher occurrence among men (141.0 million) in comparison to women (103.1 million). The market is driven by means of factors consisting of good sized improvements in catheterization system, accelerated operator understanding, the emergence of progressive strategies, and the growing incidence of cardiac complications, necessitating the establishment of cardiac catheterization labs globally.

Cardiac bio-implants market in the United States holds an enormous proportion and is projected to hold a regular growth trend at some stage in the upcoming years.

By Countries, The cardiac bio-implant devices market is broken up into the US, Canada, France, Germany, Italy, Spain, the UK, Belgium, the Netherlands, Switzerland, China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, the Philippines, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Turkey, the U.A.E., and Rest of World. The bio-implants market in the United States is driven by elements like the increasing prevalence of chronic illnesses and robust healthcare infrastructure, leading to huge growth. National health spending is projected to develop at a 5.4% annual rate, accomplishing USD 6.2 trillion by 2028. This rising healthcare expenditure creates possibilities for bio-implant improvement, whilst new product introductions like the T3 pro-tampered implant and Encode emergence healing Abutment through ZimVie further make contributions to market increase.

Key Company

F. Hoffman-La Roche, Eurofins Scientific, Illumina, Inc., Natera Inc., Abbott Laboratories, Thermo Fisher Scientific, Quest Diagnostics, and Agilent Technologies are the few companies working in the cardiac bio-implant device market.

Renub Research latest report "Cardiac Bio Implant Devices Market, Global Forecast By Type (Pacemaker, ICDs, Cardiac Resyncronization Therapy(CRT)), Application (Arrhythmias, Myocardial Ischemia, Acute Myocardial Infarction, Heart Failure), End-User (Hospitals, Ambulatory Surgical Centers', Cardiac Catheterization Laboratories, Others), Country ( United States, Canada, France, Germany, Italy, Spain, the United Kingdom, Belgium, Netherlands, Switzerland, China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, Philippines, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Turkey, U.A.E., and ROW), Companies (F. Hoffman-La Roche, Eurofins Scientific, Illumina, Inc., Natera Inc., Abbott Laboratories, Thermo Fisher Scientific, Quest Diagnostics, and Agilent Technologies)" provides a detailed analysis of Cardiac Bio Implant Devices Industry.

Type - Market have been covered from 3 viewpoints:

  • 1. Pacemaker
  • 2. ICDs (Implantable Cardioverter Defibrillator)
  • 3. CRT (Cardiac Resynchronization Therapy)

Application - Market have been covered from 4 viewpoints:

  • 1. Arrhythmias
  • 2. Myocardial Ischemia
  • 3. Acute Myocardial Infarction
  • 4. Heart Failure

End-User - Market have been covered from 4 viewpoints:

  • 1. Hospitals
  • 2. Cardiac Care Centers
  • 3. Ambulatory Centers & Home Care
  • 4. Academic Institutes
  • 5. Others

Country - Market have been covered from 27 viewpoints:

  • 1. North America
    • 1.1. United States
    • 1.2. Canada
  • 2. Europe
    • 2.1. France
    • 2.2. Germany
    • 2.3. Italy
    • 2.4. Spain
    • 2.5. United Kingdom
    • 2.6. Belgium
    • 2.7. Netherlands
    • 2.8. Switzerland
    • 2.9. Turkey
  • 3. Asia Pacific
    • 3.1. China
    • 3.2. Japan
    • 3.3. India
    • 3.4. Australia
    • 3.5. South Korea
    • 3.6. Thailand
    • 3.7. Malaysia
    • 3.8. Indonesia
    • 3.9. Philippines
  • 4. Latin America
    • 4.1. Brazil
    • 4.2. Mexico
    • 4.3. Argentina
  • 5. Middle East & Africa
    • 5.1. Saudi Arabia
    • 5.2. U.A.E
    • 5.3. South Africa
  • 6. Rest of World

Company Insights:

  • Overview
  • Recent Development
  • Revenue

Companies Covered:

  • 1. F. Hoffman-La Roche
  • 2. Eurofins Scientific
  • 3. Illumina, Inc.
  • 4. Natera Inc.
  • 5. Abbott Laboratories
  • 6. Thermo Fisher Scientific
  • 7. Quest Diagnostics
  • 8. Agilent Technologies

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Cardiac Bio Implant Devices Market

6. Market Share - Cardiac Bio Implant Devices Market

  • 6.1 By Type
  • 6.2 By Application
  • 6.3 By End User
  • 6.4 By Countries

7. Type - Cardiac Bio Implant Devices Market

  • 7.1 Pacemaker
  • 7.2 ICDs (Implantable Cardioverter Defibrillator)
  • 7.3 CRT (Cardiac Resynchronization Therapy)

8. Application - Cardiac Bio Implant Devices Market

  • 8.1 Arrhythmias
  • 8.2 Myocardial Ischemia
  • 8.3 Acute Myocardial Infarction
  • 8.4 Heart Failure

9. End-User - Cardiac Bio Implant Devices Market

  • 9.1 Hospitals
  • 9.2 Ambulatory Surgical Centers
  • 9.3 Cardiac Catheterization Laboratories
  • 9.4 Others

10. Countries - Cardiac Bio Implant Devices Market

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
  • 10.2 Europe
    • 10.2.1 France
    • 10.2.2 Germany
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Belgium
    • 10.2.7 Netherlands
    • 10.2.8 Switzerland
    • 10.2.9 Turkey
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 Australia
    • 10.3.5 South Korea
    • 10.3.6 Thailand
    • 10.3.7 Malaysia
    • 10.3.8 Indonesia
    • 10.3.9 Philippines
  • 10.4 Latin America
    • 10.4.1 Brazil
    • 10.4.2 Mexico
    • 10.4.3 Argentina
  • 10.5 Middle East & Africa
    • 10.5.1 Saudi Arabia
    • 10.5.2 U.A.E
    • 10.5.3 South Africa
  • 10.6 Rest of World

11. Porter Five Forces Analysis - Cardiac Bio Implant Devices Market

  • 11.1 Bargaining Power of Buyers
  • 11.2 Bargaining Power of Suppliers
  • 11.3 Degree of Rivalry
  • 11.4 Threat of New Entrants
  • 11.5 Threat of Substitutes

12. SWOT Analysis - Cardiac Bio Implant Devices Market

  • 12.1 Strength
  • 12.2 Weakness
  • 12.3 Opportunity
  • 12.4 Threat

13. Key Players Analysis

  • 13.1 F. Hoffman-La Roche
    • 13.1.1 Overview
    • 13.1.2 Recent Development
    • 13.1.3 SWOT Analysis
    • 13.1.4 Revenue
  • 13.2 Eurofins Scientific
    • 13.2.1 Overview
    • 13.2.2 Recent Development
    • 13.2.3 SWOT Analysis
    • 13.2.4 Revenue
  • 13.3 Illumina, Inc.
    • 13.3.1 Overview
    • 13.3.2 Recent Development
    • 13.3.3 SWOT Analysis
    • 13.3.4 Revenue
  • 13.4 Natera Inc.
    • 13.4.1 Overview
    • 13.4.2 Recent Development
    • 13.4.3 SWOT Analysis
    • 13.4.4 Revenue
  • 13.5 Abbott Laboratories
    • 13.5.1 Overview
    • 13.5.2 Recent Development
    • 13.5.3 SWOT Analysis
    • 13.5.4 Revenue
  • 13.6 Thermo Fisher Scientific
    • 13.6.1 Overview
    • 13.6.2 Recent Development
    • 13.6.3 SWOT Analysis
    • 13.6.4 Revenue
  • 13.7 Quest Diagnostics
    • 13.7.1 Overview
    • 13.7.2 Recent Development
    • 13.7.3 SWOT Analysis
    • 13.7.4 Revenue
  • 13.8 Agilent Technologies
    • 13.8.1 Overview
    • 13.8.2 Recent Development
    • 13.8.3 SWOT Analysis
    • 13.8.4 Revenue

List of Figures

  • Figure-01: Global - Cardiac Bio Implant Devices Market (Billion US$), 2018 - 2022
  • Figure-02: Global - Forecast for Cardiac Bio Implant Devices Market (Billion US$), 2023 - 2030
  • Figure-03: Type - Pacemaker Market (Billion US$), 2018 - 2022
  • Figure-04: Type - Forecast for Pacemaker Market (Billion US$), 2023 - 2030
  • Figure-05: Type - ICDs (Implantable Cardioverter Defibrillator) Market (Billion US$), 2018 - 2022
  • Figure-06: Type - Forecast for ICDs (Implantable Cardioverter Defibrillator) Market (Billion US$), 2023 - 2030
  • Figure-07: Type - CRT (Cardiac Resynchronization Therapy) Market (Billion US$), 2018 - 2022
  • Figure-08: Type - Forecast for CRT (Cardiac Resynchronization Therapy) Market (Billion US$), 2023 - 2030
  • Figure-09: Application - Arrhythmias Market (Billion US$), 2018 - 2022
  • Figure-10: Application - Forecast for Arrhythmias Market (Billion US$), 2023 - 2030
  • Figure-11: Application - Myocardial Ischemia Market (Billion US$), 2018 - 2022
  • Figure-12: Application - Forecast for Myocardial Ischemia Market (Billion US$), 2023 - 2030
  • Figure-13: Application - Acute Myocardial Infarction Market (Billion US$), 2018 - 2022
  • Figure-14: Application - Forecast for Acute Myocardial Infarction Market (Billion US$), 2023 - 2030
  • Figure-15: Application - Heart Failure Market (Billion US$), 2018 - 2022
  • Figure-16: Application - Forecast for Heart Failure Market (Billion US$), 2023 - 2030
  • Figure-17: End-User - Hospitals Market (Billion US$), 2018 - 2022
  • Figure-18: End-User - Forecast for Hospitals Market (Billion US$), 2023 - 2030
  • Figure-19: End-User - Ambulatory Surgical Centers Market (Billion US$), 2018 - 2022
  • Figure-20: End-User - Forecast for Ambulatory Surgical Centers Market (Billion US$), 2023 - 2030
  • Figure-21: End-User - Cardiac Catheterization Laboratories Market (Billion US$), 2018 - 2022
  • Figure-22: End-User - Forecast for Cardiac Catheterization Laboratories Market (Billion US$), 2023 - 2030
  • Figure-23: End-User - Others Market (Billion US$), 2018 - 2022
  • Figure-24: End-User - Forecast for Others Market (Billion US$), 2023 - 2030
  • Figure-25: United States - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-26: United States - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-27: Canada - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-28: Canada - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-29: France - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-30: France - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-31: Germany - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-32: Germany - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-33: Italy - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-34: Italy - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-35: Spain - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-36: Spain - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-37: United Kingdom - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-38: United Kingdom - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-39: Belgium - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-40: Belgium - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-41: Netherlands - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-42: Netherlands - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-43: Switzerland - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-44: Switzerland - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-45: Turkey - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-46: Turkey - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-47: China - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-48: China - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-49: Japan - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-50: Japan - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-51: India - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-52: India - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-53: Australia - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-54: Australia - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-55: South Korea - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-56: South Korea - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-57: Thailand - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-58: Thailand - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-59: Malaysia - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-60: Malaysia - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-61: Indonesia - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-62: Indonesia - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-63: Philippines - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-64: Philippines - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-65: Brazil - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-66: Brazil - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-67: Mexico - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-68: Mexico - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-69: Argentina - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-70: Argentina - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-71: Saudi Arabia - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-72: Saudi Arabia - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-73: United Arab Emirates (UAE) - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-74: United Arab Emirates (UAE) - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-75: South Africa - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-76: South Africa - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-77: Rest of the World - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-78: Rest of the World - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-79: F. Hoffman-La Roche - Global Revenue (Billion US$), 2018 - 2022
  • Figure-80: F. Hoffman-La Roche - Forecast for Global Revenue (Billion US$), 2023 - 2030
  • Figure-81: Eurofins Scientific - Global Revenue (Billion US$), 2018 - 2022
  • Figure-82: Eurofins Scientific - Forecast for Global Revenue (Billion US$), 2023 - 2030
  • Figure-83: Illumina, Inc. - Global Revenue (Billion US$), 2018 - 2022
  • Figure-84: Illumina, Inc. - Forecast for Global Revenue (Billion US$), 2023 - 2030
  • Figure-85: Natera Inc. - Global Revenue (Million US$), 2018 - 2022
  • Figure-86: Natera Inc. - Forecast for Global Revenue (Million US$), 2023 - 2030
  • Figure-87: Abbott Laboratories - Global Revenue (Billion US$), 2018 - 2022
  • Figure-88: Abbott Laboratories - Forecast for Global Revenue (Billion US$), 2023 - 2030
  • Figure-89: Thermo Fisher Scientific - Global Revenue (Billion US$), 2018 - 2022
  • Figure-90: Thermo Fisher Scientific - Forecast for Global Revenue (Billion US$), 2023 - 2030
  • Figure-91: Quest Diagnostics - Global Revenue (Billion US$), 2018 - 2022
  • Figure-92: Quest Diagnostics - Forecast for Global Revenue (Billion US$), 2023 - 2030
  • Figure-93: Agilent Technologies - Global Revenue (Billion US$), 2018 - 2022
  • Figure-94: Agilent Technologies - Forecast for Global Revenue (Billion US$), 2023 - 2030

List of Tables

  • Table-01: Global - Cardiac Bio Implant Devices Market Share by Type (Percent), 2018 - 2022
  • Table-02: Global - Forecast for Cardiac Bio Implant Devices Market Share by Type (Percent), 2023 - 2030
  • Table-03: Global - Cardiac Bio Implant Devices Market Share by Application (Percent), 2018 - 2022
  • Table-04: Global - Forecast for Cardiac Bio Implant Devices Market Share by Application (Percent), 2023 - 2030
  • Table-05: Global - Cardiac Bio Implant Devices Market Share by End-User (Percent), 2018 - 2022
  • Table-06: Global - Forecast for Cardiac Bio Implant Devices Market Share by End-User (Percent), 2023 - 2030
  • Table-07: Global - Cardiac Bio Implant Devices Market Share by Countries (Percent), 2018 - 2022
  • Table-08: Global - Forecast for Cardiac Bio Implant Devices Market Share by Countries (Percent), 2023 - 2030